Scalp Seborrheic Dermatitis in Adults When Topical Therapy Has Not Worked
This protocol is for adult patients with seborrheic dermatitis of the scalp whose symptoms — erythema, scaling, and pruritus — have not been adequately controlled by standard topical first-line treatment. When topical scalp therapy does not achieve the expected reduction in these signs, a different approach is warranted.
Previous Treatment — Goals Not Reached
The first step in adult scalp SD is topical scalp therapy using agents with antifungal, anti-inflammatory, or keratolytic/humectant properties. When this treatment fails to produce meaningful reduction in scalp erythema, scaling, and pruritus, the condition calls for escalation to the next treatment line.
Clinical Goals
The objective at this stage is prompt reduction of seborrheic dermatitis symptoms and skin inflammation, with a target of complete clearing or marked improvement.
Next-Step Approach — Partial Overview
When topical therapy has proven insufficient — particularly in acute, severe, or resistant presentations — a systemic antifungal approach becomes the indicated path. The complete protocol, including agent selection and all clinical details, is available via the link below.
References
- DOI: 10.2147/CCID.S284671
- In adults, the use of topical agents with antifungal (ketoconazole, ciclopirox, miconazole), antiinflammatory (betamethasone valerate, clobetasol propionate) or keratolytic/humectant (propylene glycol) properties is strongly recommended (Table 1).
- Systemic antifungals (terbinafine, itraconazole) are mainly indicated in acute and/or severe and/or resistant adult SD forms, as well as in selected and difficult-to-treat conditions.
- In these cases, the goal of systemic approach is the prompt reduction of symptoms and the possibility to use topical agents as a maintenance therapy.
View source ↗